McCurrach,  M. E., Connor,  T. M., Knudson,  C. M., Korsmeyer,  S. J., Lowe,  S. W.
  
(March 1997)
bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis.
    Proceedings of the National Academy of Sciences of the United States of America, 94 (6).
     pp. 2345-9.
     ISSN 0027-8424
    
  
  
  
  
  
    
  
    
      
      
    
  
  
    
  
  
  
    Abstract
    Inactivation of p53-dependent apoptosis promotes oncogenic transformation, tumor development, and resistance to many cytotoxic anticancer agents. p53 can transcriptionally activate bax, a bcl-2 family member that promotes apoptosis. To determine whether bax is required for p53-dependent apoptosis, the effects of bax deficiency were examined in primary fibroblasts expressing the E1A oncogene, a setting where apoptosis is dependent on endogenous p53. We demonstrate that bax can function as an effector of p53 in chemotherapy-induced apoptosis and contributes to a p53 pathway to suppress oncogenic transformation. Furthermore, we show that additional p53 effectors participate in these processes. These p53-controlled factors act synergistically with Bax to promote a full apoptotic response, and their action is suppressed by the Bcl-2 and E1B 19K oncoproteins. These studies demonstrate that Bax is a determinant of p53-dependent chemosensitivity and illustrate how p53 can promote apoptosis by coordinating the activities of multiple effectors.
  
  
    
      | Item Type: | Paper | 
    
    
      
    
      
    
      
        
          | Uncontrolled Keywords: | Animals
Apoptosis
Cell Survival/drug effects
Cell Transformation, Neoplastic
Cells, Cultured
Cisplatin/pharmacology
Crosses, Genetic
Doxorubicin/pharmacology
Drug Resistance/ genetics
Embryo
Etoposide/pharmacology
Fibroblasts
Genes, p53
Mice
Mice, Knockout
Proto-Oncogene Proteins/ deficiency/genetics
Proto-Oncogene Proteins c-bcl-2
RNA, Messenger/biosynthesis
Recombination, Genetic
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Transcription, Genetic
Tumor Suppressor Protein p53/biosynthesis/metabolism
bcl-2-Associated X Protein | 
      
    
      
        
          | Subjects: | organs, tissues, organelles,  cell types and functions > cell types and functions > cell functions > apoptosis organism description > animal > developmental stage > embryo
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types > fibroblasts
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types > fibroblasts
 organs, tissues, organelles,  cell types and functions > cell types and functions > cell types > fibroblasts
 bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification > genes, structure and function > genes: types > p53
 bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification > genes, structure and function > genes: types > tumor suppressor
 | 
      
    
      
        
          | CSHL Authors: |  | 
      
    
      
        
          | Communities: | CSHL labs > Lowe lab | 
      
    
      
    
      
    
      
        
          | Depositing User: | Kathleen Darby | 
      
    
      
        
          | Date: | 18 March 1997 | 
      
    
      
        
          | Date Deposited: | 08 May 2014 14:58 | 
      
    
      
        
          | Last Modified: | 11 Sep 2019 16:32 | 
      
    
      
        
          | PMCID: | PMC20090 | 
      
    
      
        
          | Related URLs: |  | 
      
    
      
    
    
      | URI: | https://repository.cshl.edu/id/eprint/29984 | 
  
  
  
  
    Actions (login required)
    
    
      
        |  | Administrator's edit/view item |